Format

Send to

Choose Destination
Trends Genet. 2012 Oct;28(10):487-95. doi: 10.1016/j.tig.2012.06.008. Epub 2012 Jul 26.

Relating human genetic variation to variation in drug responses.

Author information

1
Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL, USA.

Abstract

Although sequencing a single human genome was a monumental effort a decade ago, more than 1000 genomes have now been sequenced. The task ahead lies in transforming this information into personalized treatment strategies that are tailored to the unique genetics of each individual. One important aspect of personalized medicine is patient-to-patient variation in drug response. Pharmacogenomics addresses this issue by seeking to identify genetic contributors to human variation in drug efficacy and toxicity. Here, we present a summary of the current status of this field, which has evolved from studies of single candidate genes to comprehensive genome-wide analyses. Additionally, we discuss the major challenges in translating this knowledge into a systems-level understanding of drug physiology, with the ultimate goal of developing more effective personalized clinical treatment strategies.

PMID:
22840197
PMCID:
PMC3448823
DOI:
10.1016/j.tig.2012.06.008
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center